Preliminary tolerability assessment of naxitamab (humanized anti-GD-2 monoclonal antibody) therapy in a phase 2 osteosarcoma trial Meeting Abstract
| Authors: | Dela Cruz, F.; Chou, A.; Roberts, S.; Mauguen, A.; Bonura, J.; Hilliard, J.; Namuduri, M.; Ortiz, M.; Slotkin, E.; Wexler, L.; Glade Bender, J.; Kothari, P.; Heaton, T.; LaQuaglia, M.; Price, A.; Meyers, P. |
| Abstract Title: | Preliminary tolerability assessment of naxitamab (humanized anti-GD-2 monoclonal antibody) therapy in a phase 2 osteosarcoma trial |
| Meeting Title: | 51st Congress of the International Society of Paediatric Oncology (SIOP) |
| Journal Title: | Pediatric Blood and Cancer |
| Volume: | 66 |
| Issue: | Suppl. 4 |
| Meeting Dates: | 2019 Oct 23-26 |
| Meeting Location: | Lyon, France |
| ISSN: | 1545-5009 |
| Publisher: | Wiley Periodicals, Inc |
| Date Published: | 2019-12-01 |
| Start Page: | S292 |
| End Page: | S293 |
| Language: | English |
| ACCESSION: | WOS:000488458003119 |
| PROVIDER: | wos |
| PUBMED: | 31568621 |
| DOI: | 10.1002/pbc.27989 |
| Notes: | Meeting Abstract: V262 SIOP19-1718 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
Related MSK Work